Cargando…
Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
Tumor-associated macrophages (TAMs) play critical roles in tumor progression but are also capable of contributing to antitumor immunity. Recent studies have revealed an unprecedented heterogeneity among TAMs in both human cancer and experimental models. Nevertheless, we still understand little about...
Autores principales: | Etzerodt, Anders, Tsalkitzi, Kyriaki, Maniecki, Maciej, Damsky, William, Delfini, Marcello, Baudoin, Elodie, Moulin, Morgane, Bosenberg, Marcus, Graversen, Jonas Heilskov, Auphan-Anezin, Nathalie, Moestrup, Søren Kragh, Lawrence, Toby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781002/ https://www.ncbi.nlm.nih.gov/pubmed/31375534 http://dx.doi.org/10.1084/jem.20182124 |
Ejemplares similares
-
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015) -
Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
por: Etzerodt, Anders, et al.
Publicado: (2020) -
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020) -
Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017) -
The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
por: Thomsen, Jens Haugbølle, et al.
Publicado: (2013)